Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yulian Xie, Limei Wang, Yi Luo, Hailin Chen, Yunjie Yang, Qianqian Shen & Guangwen Cao. (2023) LINC02489 with m6a modification increase paclitaxel sensitivity by inhibiting migration and invasion of ovarian cancer cells. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-15.
Read now
Read now
Yitian Xu & Chen Huang. (2022) Progress and application of epitranscriptomic m6A modification in gastric cancer. RNA Biology 19:1, pages 885-896.
Read now
Read now
Lisi Zeng, Quanxing Liao, Xiaohui Zeng, Jiacai Ye, Xianzi Yang, Siyu Zhu, Hongsheng Tang, Gaojie Liu, Weiwen Cui, Shaohua Ma & Shuzhong Cui. (2022) Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer. Bioengineered 13:2, pages 2623-2638.
Read now
Read now
Guoping Wang, Zhongchen Zhang & Chenmei Xia. (2021) Long non-coding RNA LINC00240 promotes gastric cancer progression via modulating miR-338-5p/METTL3 axis. Bioengineered 12:2, pages 9678-9691.
Read now
Read now
Articles from other publishers (30)
Jiaxin Wang, Guiping Zhao, Yan Zhao, Zheng Zhao, Shuyue Yang, Anni Zhou, Peng Li & Shutian Zhang. (2024)
N
6
-methylation in the development, diagnosis, and treatment of gastric cancer
. Journal of Translational Internal Medicine 12:1, pages 5-21.
Crossref
Crossref
Mehrdad Hashemi, Pouria Daneii, Mohammad Arad Zandieh, Rasoul Raesi, Neda Zahmatkesh, Mehrsa Bayat, Anwar Abuelrub, Zeinab Khazaei Koohpar, Amir Reza Aref, Ali Zarrabi, Mohsen Rashidi, Shokooh Salimimoghadam, Maliheh Entezari, Afshin Taheriazam & Ramin Khorrami. (2024) Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response. Non-coding RNA Research 9:1, pages 84-104.
Crossref
Crossref
Liping Tan, Shuangan Wang, Shijia Huang, Yujuan Tie, Na Sai, Yichen Mao, Shuli Zhao, Yayi Hou & Huan Dou. (2024)
FoxO1 promotes ovarian cancer by increasing transcription and METTL14‐mediated m
6
A modification of SMC4
. Cancer Science.
Crossref
Crossref
Liqiong Yang, Lu Tang, Qi Min, Hua Tian, Linwei Li, Yueshui Zhao, Xu Wu, Mingxing Li, Fukuan Du, Yu Chen, Wanping Li, Xiaobing Li, Meijuan Chen, Li Gu, Yuhong Sun, Zhangang Xiao & Jing Shen. (2024) Emerging role of RNA modification and long noncoding RNA interaction in cancer. Cancer Gene Therapy.
Crossref
Crossref
Chunming Zhu, Jun Yang, Chengpu Zhang, Yibing Wang & Jiahe Wang. (2024) Knowledge mapping and current trends of m6A methylation in the field of cancer. Heliyon 10:4, pages e26262.
Crossref
Crossref
Chen Peng, Fen Xiong, Xi Pu, Zhangmin Hu, Yufei Yang, Xuehan Qiao, Yuchun Jiang, Miao Han, Deqiang Wang & Xiaoqin Li. (2023) m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy. Frontiers in Immunology 14.
Crossref
Crossref
Bing Guo, Gaopeng Cheng & Guang Chen. (2023)
The m
6
A-Mediated LINC00857 Upregulation Facilitates Glioma Migration, Invasion and Vasculogenic Mimicry Formation
. Journal of Biomaterials and Tissue Engineering 13:10, pages 968-977.
Crossref
Crossref
Jiexuan Hu, Haishan Lin, Cong Wang, Qiang Su & Bangwei Cao. (2023) METTL14‑mediated RNA methylation in digestive system tumors. International Journal of Molecular Medicine 52:3.
Crossref
Crossref
Nian Liu, Chao Zhang & Liang Zhang. (2023) WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer. Molecular Biotechnology.
Crossref
Crossref
Si-Qi Ding, Xue-Ping Zhang, Jun-Peng Pei, Xiao Bai, Jin-Jie Ma, Chun-Dong Zhang & Dong-Qiu Dai. (2023) Role of N6-methyladenosine RNA modification in gastric cancer. Cell Death Discovery 9:1.
Crossref
Crossref
Jinli Li, Fatemeh Momen‐Heravi, Xun Wu & Kaili He. (2022) Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells. Oral Diseases 29:5, pages 2012-2026.
Crossref
Crossref
Nan Zhang, Yifei Sun, Zongqin Mei, Zuoshun He & Shiyan Gu. (2023) Novel insights into mutual regulation between N6-methyladenosine modification and LncRNAs in tumors. Cancer Cell International 23:1.
Crossref
Crossref
Jinxin Tang, Jinhui Zhang, Yu Lu, Jieyu He, Hua Wang, Binfeng Liu, Chao Tu & Zhihong Li. (2023) Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications. Biomarker Research 11:1.
Crossref
Crossref
Yili Ping, Jingjuan Huang, Jichao Zhu, Zujun Sun, Anquan Shang, Chen Chen, Wenfang Liu & Dong Li. (2023) Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m6A-modified long non-coding RNAs in lung adenocarcinoma. Clinical Epigenetics 15:1.
Crossref
Crossref
Ziying Liu, Lei Gao, Long Cheng, Gaoyuan Lv, Bei Sun, Gang Wang & Qiushi Tang. (2023) The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications. Experimental & Molecular Medicine 55:3, pages 487-501.
Crossref
Crossref
Yating Xu, Xiao Yu, Wenzhi Guo & Yuting He. (2023) Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers. Frontiers in Immunology 14.
Crossref
Crossref
Tiannan Ji, Xiaohui Gao, Dan Li, Siyuan Huai, Yajing Chi, Xian An, Wenyu Ji, Siming Yang & Jianxiong Li. (2023) Identification and validation of signature for prognosis and immune microenvironment in gastric cancer based on m6A demethylase ALKBH5. Frontiers in Oncology 12.
Crossref
Crossref
Abolfazl Akbari, Somayeh Abbasi, Nasrin Borumandnia, Zahra Shokati Eshkiki, Meghdad Sedaghat, Seidamir Pasha Tabaeian, Amirhossein Faghihi Kashani & Atefeh Talebi. (2022) Epigenetic regulation of gastrointestinal cancers mediated by long non-coding RNAs. Cancer Biomarkers 35:4, pages 359-377.
Crossref
Crossref
Gaofeng Li, Qiru Fu, Cong Liu, Yuxi Peng, Jun Gong, Shilan Li, Yan Huang & Haiyuan Zhang. (2022) The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets. Frontiers in Oncology 12.
Crossref
Crossref
Shuyu Xu, Wenlong Chen, Yiwen Wang, Yuxin Zhang, Rong Xia, Jiemiao Shen, Xing Gong, Yinyin Liang, Jiayi Xu, Hua Tang, Tie Zhao, Yi Zhang, Tao Chen & Chao Wang. (2022) N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients. BMC Cancer 22:1.
Crossref
Crossref
Yingjie He, Xuezhi Du, Ming Chen, Lei Han & Jinjin Sun. (2022)
Novel insight into the functions of N
6
‑methyladenosine modified lncRNAs in cancers (Review)
. International Journal of Oncology 61:6.
Crossref
Crossref
Xuemei Zeng, Juan Xiao, Xue Bai, Yiwen Liu, Meilan Zhang, Jiangrong Liu, Zixuan Lin & Zhiwei Zhang. (2022) Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer. Pathology - Research and Practice 238, pages 154030.
Crossref
Crossref
Bin Shi, Wei-Wei Liu, Ke Yang, Guan-Min Jiang & Hao Wang. (2022) The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer. Molecular Cancer 21:1.
Crossref
Crossref
Lin Luo, Yingwei Zhen, Dazhao Peng, Cheng Wei, Xiaoyang Zhang, Xianzhi Liu, Lei Han & Zhenyu Zhang. (2022) The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer. Cell Death Discovery 8:1.
Crossref
Crossref
Yingqian Peng, Zicong Wang, Bingyan Li, Wei Tan, Jingling Zou, Yun Li, Shigeo Yoshida & Yedi Zhou. (2022) N6-methyladenosine modifications of mRNAs and long noncoding RNAs in oxygen-induced retinopathy in mice. Experimental Eye Research 220, pages 109114.
Crossref
Crossref
Na Luo, Min Fu, Yiling Zhang, Xiaoyu Li, Wenjun Zhu, Feng Yang, Ziqi Chen, Qi Mei, Xiaohong Peng, Lulu Shen, Yuanyuan Zhang, Qianxia Li & Guangyuan Hu. (2022) Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Wenzhang Wu, Fan Zhang, Jun Zhao, Puyi He & Yumin Li. (2022) The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer. Experimental Cell Research 415:2, pages 113115.
Crossref
Crossref
Chen Xue, Qingfei Chu, Qiuxian Zheng, Shiman Jiang, Zhengyi Bao, Yuanshuai Su, Juan Lu & Lanjuan Li. (2022) Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Yize Li, Hongyan Peng, Peng Jiang, Jiarui Zhang, Yongmei Zhao, Xuelian Feng, Cui Pang, Jingyi Ren, Hongmei Zhang, Wendong Bai & Wenchao Liu. (2022) Downregulation of Methyltransferase-Like 14 Promotes Ovarian Cancer Cell Proliferation Through Stabilizing TROAP mRNA. Frontiers in Oncology 12.
Crossref
Crossref
Xin Liu, Yuping Du, Zhenghao Huang, Honglei Qin, Jingwen Chen & Yang Zhao. (2021) Insights into roles of METTL14 in tumors. Cell Proliferation 55:1.
Crossref
Crossref